Hologic, Inc.
NasdaqGS:HOLX
Sector
Industries
Location
Market Cap
USD 14.48 B
Share Price
USD 64.98
Avg Daily Volume
3,483,828
Change (1 day)
-1.60%
Change (1 year)
-21.25%
Change (YTD)
-9.86%
Hologic, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 29, 2025: USD 1.13 B
Hologic, Inc. Operating Cash Flow is USD 1.13 B for the Trailing 12 Months (TTM) ending March 29, 2025, a 2.50% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
Hologic, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 30, 2024 was USD 1.10 B, a 15.11% change year over year.
-
Hologic, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending April 01, 2023 was USD 959.00 M, a -65.19% change year over year.
-
Hologic, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 26, 2022 was USD 2.75 B, a 47.53% change year over year.
-
Hologic, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 27, 2021 was USD 1.87 B, a 190.39% change year over year.
StockViz
Competitors
Boston Scientific Corporation
USD 106.76
BSX
+0.29
0.27%
Siemens Healthineers AG
USD 56.43
SHL.DE
+0.40
0.71%
Edwards Lifesciences Corporation
USD 81.16
EW
+0.69
0.86%
GE HealthCare Technologies Inc.
USD 71.64
GEHC
-6.08
-7.82%
DexCom, Inc.
USD 89.06
DXCM
-0.29
-0.33%
Laboratory Corporation of America Holdings
USD 263.91
LH
+2.19
0.84%
Natera, Inc.
USD 140.96
NTRA
+5.12
3.77%
Baxter International Inc.
USD 28.05
BAX
-0.79
-2.74%
Fisher & Paykel Healthcare Corporation Limited
USD 21.67
FPH.NZ
-0.35
-1.60%
Exact Sciences Corporation
USD 46.80
EXAS
-0.74
-1.56%
Penumbra, Inc.
USD 254.21
PEN
+27.06
11.91%
Hangzhou Tigermed Consulting Co., Ltd.
USD 7.27
3347.HK
+0.01
0.19%
ConvaTec Group Plc
USD 3.06
CTEC.L
-0.20
-6.25%
Shenzhen New Industries Biomedical Engineering Co., Ltd.
USD 7.75
300832.SZ
-0.23
-2.84%
APT Medical Inc.
USD 40.51
688617.SS
+0.52
1.31%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|
Competitors
Boston Scientific Corporation
USD 106.76
BSX
+0.29
0.27%
Siemens Healthineers AG
USD 56.43
SHL.DE
+0.40
0.71%
Edwards Lifesciences Corporation
USD 81.16
EW
+0.69
0.86%
GE HealthCare Technologies Inc.
USD 71.64
GEHC
-6.08
-7.82%
DexCom, Inc.
USD 89.06
DXCM
-0.29
-0.33%
Laboratory Corporation of America Holdings
USD 263.91
LH
+2.19
0.84%
Natera, Inc.
USD 140.96
NTRA
+5.12
3.77%
Baxter International Inc.
USD 28.05
BAX
-0.79
-2.74%
Fisher & Paykel Healthcare Corporation Limited
USD 21.67
FPH.NZ
-0.35
-1.60%
Exact Sciences Corporation
USD 46.80
EXAS
-0.74
-1.56%
Penumbra, Inc.
USD 254.21
PEN
+27.06
11.91%
Hangzhou Tigermed Consulting Co., Ltd.
USD 7.27
3347.HK
+0.01
0.19%
ConvaTec Group Plc
USD 3.06
CTEC.L
-0.20
-6.25%
Shenzhen New Industries Biomedical Engineering Co., Ltd.
USD 7.75
300832.SZ
-0.23
-2.84%
APT Medical Inc.
USD 40.51
688617.SS
+0.52
1.31%